Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001546887-12-000001
Filing Date
2012-04-10
Accepted
2012-04-10 13:03:15
Documents
1
Effectiveness Date
2012-04-10
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5672
  Complete submission text file 0001546887-12-000001.txt   6738
Mailing Address 22 FIRSTFIELD ROAD SUITE 280 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 280 GAITHERSBURG MD 20878 301-861-0009
Noble Life Sciences, Inc. (Filer) CIK: 0001546887 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-176430 | Film No.: 12751445